epilepsy

Preeclampsia as a harbinger of longer-term cerebral damageA study looks at the long-term impact that preeclampsia can have on mothers' brains. Plus: A study examines the impact of maternal obesity on a child's risk of childhood epilepsy.
How one hospital reduced pediatric epilepsy emergency visits, admissionsNationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project.
FDA approves brivaracetam for use in partial onset seizure treatmentBrivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.
How physicians can guide seizure management in schoolsSeizures can be serious and scary in schools, but AAP guidelines say action plans outlining rescue medications and interventions can help.
FDA clears new treatment for epileptic seizuresFDA has approved brivaracetam (Briviact, UCB, Inc.) as an add-on therapy for the treatment of partial onset-seizures in patients with epilepsy.
Helping your epileptic patient
Helping your epileptic patientAn overview of anti-epileptic drugs and their use during pregnancy, as well as other perinatal considerations for women with seizure disorders.
Top 4 future impacts of 3D printed drugsFDA’s approval of the first 3D-printed pill – Spritam to control epileptic seizures – will have a major impact on the medical and pharmaceutical community as a whole.
FDA approves first 3D epilepsy drugFDA approved epilepsy drug levetiracetam (Spritam), the first FDA-approved drug that utilizes three-dimensional printing (3DP).
Children with cerebral palsy, epilepsy need flu vaccine but don’t always get itChildren who have neurological disorders such as cerebral palsy or epilepsy are no more likely to be vaccinated against influenza than children without these conditions, despite the increased risk for complications from flu these children experience, according to a study published online April 9 in Vaccine. Moreover, healthcare providers may not be familiar with the increased risk among these patients to effectively recommend influenza vaccine.
FDA drug approvals-March 2015FDA actions in brief, breakthrough designation, recommended for approval, priority review, fast-track designations